We are live on ! Find out more
FDCDDQ

Federation des caisses Desjardins du Quebec Portfolio holdings

AUM $27.8B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-14.6%
1 Year Est. Return
+31.66%
3 Year Est. Return
+71.4%
5 Year Est. Return
+81.76%
10 Year Est. Return
AUM
$8.98B
AUM Growth
-$1.37B
Cap. Flow
+$198M
Cap. Flow %
2.2%
Top 10 Hldgs %
23.88%
Holding
2,630
New
83
Increased
746
Reduced
565
Closed
95

Sector Composition

Rank Sector Weight
1 Financials 27.28%
2 Technology 12.05%
3 Communication Services 8.94%
4 Healthcare 8.66%
5 Industrials 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSTB.WS
2301
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$320 ﹤0.01%
4,000
LOGC
2302
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$315 ﹤0.01%
900
DPRO
2303
Draganfly
DPRO
$163M
$313 ﹤0.01%
14
AXIA.PR
2304
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
$311 ﹤0.01%
44
ASTC icon
2305
Astrotech Corp
ASTC
$18.9M
$301 ﹤0.01%
23
TISI icon
2306
Team
TISI
$104M
$297 ﹤0.01%
40
GOEVW
2307
DELISTED
Canoo Inc. Warrant
GOEVW
$290 ﹤0.01%
1,000
PLX icon
2308
Protalix BioTherapeutics
PLX
$196M
$273 ﹤0.01%
250
-850
-77% -$994
ATHX
2309
DELISTED
Athersys, Inc. Common Stock
ATHX
$260 ﹤0.01%
40
PEI
2310
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$251 ﹤0.01%
75
-1
-1% -$7
TNXP icon
2311
Tonix Pharmaceuticals
TNXP
$212M
0
CELL
2312
DELISTED
PhenomeX Inc. Common Stock
CELL
$249 ﹤0.01%
50
HLF icon
2313
Herbalife
HLF
$1.23B
$245 ﹤0.01%
+12
New +$297
MUR icon
2314
Murphy Oil
MUR
$5.12B
$242 ﹤0.01%
8
TMQ
2315
Trilogy Metals
TMQ
$679M
$241 ﹤0.01%
317
INM icon
2316
InMed Pharmaceuticals
INM
$7.8M
$240 ﹤0.01%
1
EDSA icon
2317
Edesa Biotech
EDSA
$53.2M
$217 ﹤0.01%
19
DFIN icon
2318
Donnelley Financial Solutions
DFIN
$1.16B
$205 ﹤0.01%
7
GRCE
2319
Grace Therapeutics
GRCE
$44.6M
$198 ﹤0.01%
38
LCI
2320
DELISTED
Lannett Company, Inc.
LCI
$174 ﹤0.01%
75
AZRE
2321
DELISTED
Azure Power Global Limited
AZRE
$171 ﹤0.01%
15
QIPT
2322
DELISTED
Quipt Home Medical
QIPT
$169 ﹤0.01%
37
GEG icon
2323
Great Elm Group
GEG
$67.4M
$166 ﹤0.01%
77
MGNI icon
2324
Magnite
MGNI
$3.49B
$160 ﹤0.01%
18
EPIX
2325
DELISTED
ESSA Pharma
EPIX
$158 ﹤0.01%
+50
New +$279

Similar funds

Federation des caisses Desjardins du Quebec's Q2 2022 Portfolio in Review

As of Q2 2022, Federation des caisses Desjardins du Quebec held 2,630 positions worth $8.98B, down 13% from $10.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Federation des caisses Desjardins du Quebec's Q2 2022 filing shows 83 new, 746 increased, 565 reduced and 95 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 400 Mid Cap ETF: 94,638 shares worth $3.76M. The largest sale was AGF US Market Neutral Anti-Beta Fund, an estimated $38M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.

  • Federation des caisses Desjardins du Quebec's largest Q2 2022 buy was State Street SPDR Portfolio S&P 400 Mid Cap ETF: 94,638 shares worth $3.76M.
  • Federation des caisses Desjardins du Quebec added most to Invesco FTSE RAFI US 1500 Small-Mid ETF in Q2 2022, an estimated $71.9M increase.
  • Federation des caisses Desjardins du Quebec's biggest Q2 2022 reduction was AGF US Market Neutral Anti-Beta Fund, cutting an estimated $38M.
  • Federation des caisses Desjardins du Quebec fully exited Umpqua Holdings Corp in Q2 2022, selling an estimated $989K.
  • Federation des caisses Desjardins du Quebec's ten largest holdings make up 24% of its $8.98B portfolio in Q2 2022.
  • Federation des caisses Desjardins du Quebec opened 83 new positions and closed 95 in Q2 2022.
  • Federation des caisses Desjardins du Quebec's portfolio value fell 13% quarter-over-quarter to $8.98B.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2022, filed 15 Aug 2024.